The use of molecular volumetric parameters for the evaluation of Lu-177 PSMA I&T therapy response and survival

被引：0
|
作者：
Emine Acar
Özhan Özdoğan
Ayşegül Aksu
Erkan Derebek
Recep Bekiş
Gamze Çapa Kaya
机构：
[1] İzmir Kâtip Çelebi University,Department of Nuclear Medicine, Ataturk Training and Research Hospital
[2] Dokuz Eylul University,Department of Translational Oncology, Institute of Health Sciences
[3] Dokuz Eylul University,Department of Nuclear Medicine, School of Medicine
来源：
Annals of Nuclear Medicine | 2019年 / 33卷
关键词：
PSMA; MTV; TLG; Tumor volume; Precision medicine; Theranostic;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：681 / 688
页数：7
相关论文
共 38 条
  • [21] Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
    Astrid Delker
    Mirjam Schleske
    Grigory Liubchenko
    Isabella Berg
    Mathias Johannes Zacherl
    Matthias Brendel
    Franz Josef Gildehaus
    Mikhail Rumiantcev
    Sandra Resch
    Kerstin Hürkamp
    Vera Wenter
    Lena M. Unterrainer
    Peter Bartenstein
    Sibylle I. Ziegler
    Leonie Beyer
    Guido Böning
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 1280 - 1290
  • [22] Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
    Delker, Astrid
    Schleske, Mirjam
    Liubchenko, Grigory
    Berg, Isabella
    Zacherl, Mathias Johannes
    Brendel, Matthias
    Gildehaus, Franz Josef
    Rumiantcev, Mikhail
    Resch, Sandra
    Huerkamp, Kerstin
    Wenter, Vera
    Unterrainer, Lena M.
    Bartenstein, Peter
    Ziegler, Sibylle, I
    Beyer, Leonie
    Boening, Guido
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (05) : 1280 - 1290
  • [23] Radioligand Therapy With 177Lu-PSMA-I&T in Patients With Metastatic Prostate Cancer Oncological Outcomes and Toxicity Profile
    Demirkol, Mehmet Onur
    Esen, Baris
    Seymen, Huelya
    Sen, Melis
    Ucar, Burcu
    Kurtuldu, Sevgilay
    Mandel, Nil Molinas
    Bavbek, Sevil
    Falay, Okan
    Tilki, Derya
    Esen, Tarik
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (12) : E564 - E569
  • [24] Influence of dosimetry method on bone lesion absorbed dose estimates in PSMA therapy: application to mCRPC patients receiving Lu-177-PSMA-I&T
    Julia Brosch-Lenz
    Carlos Uribe
    Astrid Gosewisch
    Lena Kaiser
    Andrei Todica
    Harun Ilhan
    Franz Josef Gildehaus
    Peter Bartenstein
    Arman Rahmim
    Anna Celler
    Sibylle Ziegler
    Guido Böning
    EJNMMI Physics, 8
  • [25] Early PSA Change after [177Lu]PSMA-617 Radioligand Therapy as a Predicator of Biochemical Response and Overall Survival
    Kind, Felix
    Fassbender, Thomas F.
    Andrieux, Geoffroy
    Boerries, Melanie
    Meyer, Philipp T.
    Ruf, Juri
    CANCERS, 2022, 14 (01)
  • [26] Quantification of biochemical PSA dynamics after radioligand therapy with [177Lu]Lu-PSMA-I&T using a population pharmacokinetic/pharmacodynamic model
    Siebinga, Hinke
    de van der Veen, Berlinda J.
    de Vries-Huizing, Daphne M. V.
    Vogel, Wouter V.
    Hendrikx, Jeroen J. M. A.
    Huitema, Alwin D. R.
    EJNMMI PHYSICS, 2024, 11 (01)
  • [27] Predictive Factors of Response and Overall Survival in Patients with Castration-Resistant Metastatic Prostate Cancer Undergoing 177Lu-PSMA Therapy
    Ahmadzadehfar, Hojjat
    Essler, Markus
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (07) : 1033 - 1034
  • [28] Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [177Lu]Lu-PSMA-617
    Ahmadzadehfar, Hojjat
    Wegen, Simone
    Yordanova, Anna
    Fimmers, Rolf
    Kuerpig, Stefan
    Eppard, Elisabeth
    Wei, Xiao
    Schlenkhoff, Carl
    Hauser, Stefan
    Essler, Markus
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (09) : 1448 - 1454
  • [29] Evaluation of thresholding methods for the quantification of [68Ga]Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [177Lu]Lu-PSMA-617 radioligand therapy
    Moon Kim
    Robert Seifert
    Jana Fragemann
    David Kersting
    Jacob Murray
    Frederic Jonske
    Kelsey L. Pomykala
    Jan Egger
    Wolfgang P. Fendler
    Ken Herrmann
    Jens Kleesiek
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 2196 - 2209
  • [30] Evaluation of thresholding methods for the quantification of [68Ga]Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [177Lu]Lu-PSMA-617 radioligand therapy
    Kim, Moon
    Seifert, Robert
    Fragemann, Jana
    Kersting, David
    Murray, Jacob
    Jonske, Frederic
    Pomykala, Kelsey L.
    Egger, Jan
    Fendler, Wolfgang P.
    Herrmann, Ken
    Kleesiek, Jens
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (07) : 2196 - 2209
1234